Sun Pharmaceutical Industries Ltd (SUN.BO)
* Sun Pharmaceutical Industries clarifies on news item "UK regulator approves Sun Pharma generic drug of Tobramycin"
- Note: Reuters has not verified this story and does not vouch for its accuracy
Indian shares ended at their lowest in two weeks on Wednesday, with Tata Motors pulling the indexes down after posting disappointing results.
Feb 15 Indian shares fell on Wednesday, with Tata Motors and Sun Pharmaceutical Industries weighing on the indexes after posting disappointing results.
** Sun Pharmaceutical Industries Ltd falls as much as 3.4 pct, lowest since Feb 2
To access the newsletter, click on the link: http://share.thomsonreuters.com/assets/newsletters/Indiamorning/MNC_IN_02152017.pdf If you would like to receive this newsletter via email, please register at: https://forms.thomsonreuters.com/india-morning/ FACTORS TO WATCH 10:00 am: Power Minister Piyush Goyal and Mines Secretary Balvinder Kumar at national conclave on mines and minerals 2017 in New Delhi. 11:30 am: India Ratings briefs media on macroeconomic
MUMBAI Sun Pharmaceutical Industries, India's largest drugmaker, reported its first fall in quarterly profits in a year on Tuesday, as pricing issues and supply constraints affected sales in the United States, its largest market.
* Q3 U.S. sales up 4 pct, India sales up 5 pct (Adds CEO's comments made in conference call with analysts)
BRIEF-Sun Pharmaceutical Industries exec says co expects to be able to address Halol issues over next few qtrs
* Exec says expects to be able to address Halol issues over the next few quarters
MUMBAI, Feb 14 India's largest drugmaker Sun Pharmaceutical Industries Ltd's third-quarter profit fell below analysts' estimates due to slower sales in the United States, its largest market.